Jeffrey SK Chan
Research Interests: Echocardiography; Heart Failure; Cardiovascular Epidemiology; Predictive Risk Modelling; Trial Sequential Analysis
Biography: A medical graduate from the Chinese University of Hong Kong, Jeffrey is a medical researcher focusing on echocardiography, heart failure, and epidemiological cardiology research. He has published a number of papers in international peer-reviewed journals, and has presented in several major international conferences. He was one of the four finalists at the Young Investigator Award competition of EchoAsia 2021. Jeffrey believes firmly in the value of international research collaboration and is actively seeking collaborative opportunities in heart failure, echocardiography and risk stratification / outcome research.
Chan JSK, Harky A. Trial sequential analysis in meta-analyses: a clinically oriented approach with real world example. J Thorac Cardiovasc Surg. 2020; 162(1): 167-173. doi: 10.1016/j.jtcvs.2020.06.063 (IF 4.451)
Chan JSK. Aspirin-omitted dual antithrombotics versus triple antithrombotics: a trial sequential analysis. Eur Heart J Cardiovasc Pharmacother. 2020; 7(3):e32-e34. doi: 10.1093/ehjcvp/pvaa061 (IF 6.696)
Chan JSK, Kot TKM, Ng M, Harky A. Continuous infusion versus intermittent boluses of furosemide in acute heart failure: a systematic review and meta-analysis. J Card Fail. 2020; 26(9): 786-793. doi: 10.1016/j.cardfail.2019.11.013 (IF 3.623)